Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers that is negative for estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene PGR and breast carcinoma.